135 related articles for article (PubMed ID: 26629255)
1. Mesenchymal stem cells preconditioned with trimetazidine promote neovascularization of hearts under hypoxia/reoxygenation injury.
Hu X; Yang J; Wang Y; Zhang Y; Ii M; Shen Z; Hui J
Int J Clin Exp Med; 2015; 8(9):16991-7005. PubMed ID: 26629255
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression.
Wisel S; Khan M; Kuppusamy ML; Mohan IK; Chacko SM; Rivera BK; Sun BC; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2009 May; 329(2):543-50. PubMed ID: 19218529
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of trimetazidine on bone marrow mesenchymal stem cells viability in an ex vivo model of hypoxia and in vivo model of locally myocardial ischemia.
Xu H; Zhu G; Tian Y
J Huazhong Univ Sci Technolog Med Sci; 2012 Feb; 32(1):36-41. PubMed ID: 22282242
[TBL] [Abstract][Full Text] [Related]
4. Sevoflurane preconditioning promotes mesenchymal stem cells to relieve myocardial ischemia/reperfusion injury via TRPC6-induced angiogenesis.
Yang J; Tang L; Zhang F; Yang T; Lu T; Sun K; Sun N; Ren J; Yan M
Stem Cell Res Ther; 2021 Nov; 12(1):584. PubMed ID: 34809715
[TBL] [Abstract][Full Text] [Related]
5. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy.
Wu S; Chang G; Gao L; Jiang D; Wang L; Li G; Luo X; Qin S; Guo X; Zhang D
J Mol Med (Berl); 2018 Aug; 96(8):791-806. PubMed ID: 29955901
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia/Reoxygenation-Preconditioned Human Bone Marrow-Derived Mesenchymal Stromal Cells Rescue Ischemic Rat Cortical Neurons by Enhancing Trophic Factor Release.
Kim YS; Noh MY; Cho KA; Kim H; Kwon MS; Kim KS; Kim J; Koh SH; Kim SH
Mol Neurobiol; 2015 Aug; 52(1):792-803. PubMed ID: 25288154
[TBL] [Abstract][Full Text] [Related]
7. Trimetazidine protects umbilical cord mesenchymal stem cells against hypoxia and serum deprivation induced apoptosis by activation of Akt.
Gong X; Fan G; Wang W; Wang G
Cell Physiol Biochem; 2014; 34(6):2245-55. PubMed ID: 25562170
[TBL] [Abstract][Full Text] [Related]
8. Trimetazidine Preconditioning Potentiates the Effect of Mesenchymal Stem Cells Secretome on the Preservation of Rat Pancreatic Islet Survival and Function In Vitro.
Ahmadi F; Lotfi AS; Navaei-Nigjeh M; Kadivar M
Appl Biochem Biotechnol; 2023 Aug; 195(8):4796-4817. PubMed ID: 37184724
[TBL] [Abstract][Full Text] [Related]
9. Autophagy mediates the beneficial effect of hypoxic preconditioning on bone marrow mesenchymal stem cells for the therapy of myocardial infarction.
Zhang Z; Yang C; Shen M; Yang M; Jin Z; Ding L; Jiang W; Yang J; Chen H; Cao F; Hu T
Stem Cell Res Ther; 2017 Apr; 8(1):89. PubMed ID: 28420436
[TBL] [Abstract][Full Text] [Related]
10. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
Hu X; Yu SP; Fraser JL; Lu Z; Ogle ME; Wang JA; Wei L
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):799-808. PubMed ID: 18374759
[TBL] [Abstract][Full Text] [Related]
11. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase-dependent Autophagic Flux.
Zhong Y; Zhong P; He S; Zhang Y; Tang L; Ling Y; Fu S; Tang Y; Yang P; Luo T; Chen B; Chen A; Wang X
J Cardiovasc Pharmacol; 2017 Jun; 69(6):389-397. PubMed ID: 28581448
[TBL] [Abstract][Full Text] [Related]
13. The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome.
Jahandideh S; Maghsood F; Ghahhari NM; Lotfinia M; Mohammadi M; Johari B; Kadivar M
Tissue Cell; 2017 Oct; 49(5):597-602. PubMed ID: 28843336
[TBL] [Abstract][Full Text] [Related]
14. Can ischemic preconditioning protect against hypoxia-induced damage? Studies of contractile function in isolated perfused rat hearts.
Cave AC; Horowitz GL; Apstein CS
J Mol Cell Cardiol; 1994 Nov; 26(11):1471-86. PubMed ID: 7897671
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of mesenchymal stem cells preconditioned with hydrogen sulfide enhances repair of myocardial infarction in rats.
Xie X; Sun A; Zhu W; Huang Z; Hu X; Jia J; Zou Y; Ge J
Tohoku J Exp Med; 2012 Jan; 226(1):29-36. PubMed ID: 22186034
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kim DI
Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206
[TBL] [Abstract][Full Text] [Related]
17. Repair of Critical-Sized Mandible Defects in Aged Rat Using Hypoxia Preconditioned BMSCs with Up-regulation of Hif-1α.
Zhang J; Feng Z; Wei J; Yu Y; Luo J; Zhou J; Li Y; Zheng X; Tang W; Liu L; Long J; Li X; Jing W
Int J Biol Sci; 2018; 14(4):449-460. PubMed ID: 29725266
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic Preconditioning Increases Survival and Pro-Angiogenic Capacity of Human Cord Blood Mesenchymal Stromal Cells In Vitro.
Bader AM; Klose K; Bieback K; Korinth D; Schneider M; Seifert M; Choi YH; Kurtz A; Falk V; Stamm C
PLoS One; 2015; 10(9):e0138477. PubMed ID: 26380983
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
[TBL] [Abstract][Full Text] [Related]
20. A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization.
Hu X; Xu Y; Zhong Z; Wu Y; Zhao J; Wang Y; Cheng H; Kong M; Zhang F; Chen Q; Sun J; Li Q; Jin J; Li Q; Chen L; Wang C; Zhan H; Fan Y; Yang Q; Yu L; Wu R; Liang J; Zhu J; Wang Y; Jin Y; Lin Y; Yang F; Jia L; Zhu W; Chen J; Yu H; Zhang J; Wang J
Circ Res; 2016 Mar; 118(6):970-83. PubMed ID: 26838793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
